Humana Inc. (NYSE:HUM) Insider Timothy S. Huval Sells 3,703 Shares

Humana Inc. (NYSE:HUM) insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Humana Stock Up 3.9 %

NYSE:HUM opened at $262.47 on Friday. The stock has a 50-day simple moving average of $272.60 and a 200 day simple moving average of $313.96. Humana Inc. has a one year low of $213.31 and a one year high of $471.37. The company has a market capitalization of $31.60 billion, a price-to-earnings ratio of 23.25, a price-to-earnings-growth ratio of 2.12 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Sell-side analysts predict that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. Humana’s payout ratio is currently 31.36%.

Analysts Set New Price Targets

HUM has been the topic of a number of research reports. Barclays raised their price objective on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Truist Financial reduced their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday, October 11th. Royal Bank of Canada cut their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target for the company in a research report on Tuesday, October 8th. Finally, Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $300.50.

Institutional Investors Weigh In On Humana

A number of institutional investors have recently modified their holdings of HUM. Moors & Cabot Inc. boosted its stake in Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after acquiring an additional 40 shares during the period. OLD National Bancorp IN lifted its holdings in shares of Humana by 1.8% in the 3rd quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock worth $828,000 after purchasing an additional 45 shares during the last quarter. Your Advocates Ltd. LLP lifted its holdings in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the last quarter. Brooklyn Investment Group grew its stake in Humana by 6.7% during the 3rd quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider’s stock worth $233,000 after buying an additional 46 shares during the last quarter. Finally, Deseret Mutual Benefit Administrators increased its position in Humana by 18.4% in the second quarter. Deseret Mutual Benefit Administrators now owns 303 shares of the insurance provider’s stock worth $113,000 after buying an additional 47 shares during the period. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.